Efficacy of one-day quadruple therapy for H pylori infection in Chinese patients

被引:5
作者
Huo, Xiao-Hui
Chu, Jian-Kun
Yang, Xiu-Fen
Wang, Jing
Zhang, Li-Jing
Ma, Jin-Cheng
Yu, Jun
机构
[1] Hebei Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Shijiazhuang, Hebei Prov, Peoples R China
[2] Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China
关键词
H pylori; quadruple therapy; antibiotics; gastritis; side effects;
D O I
10.3748/wjg.v12.i19.3105
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To compare the efficacies of one-day quadruple therapy and seven-day triple therapy in Chinese patients. METHODS: Sixty consecutive patients with nonulcer dyspepsia and confirmed H pylori infection were randomized to receive either omeprazole 40 mg, amoxycillin 1 g, and furazolidone 100 mg, all twice a day for 7 d or omeprazole 20 mg (at breakfast and dinner), amoxicillin 1 g, furazolidone 200 mg, and colloidal bismuth subcitrate 220 mg four times for only one day. H pylori status was determined before and at least 5 weeks after therapy by endoscopy with antral and corpus biopsies for rapid urease test and histology. RESULTS: H pylori eradication was successful in 66.67% (20/30) patients in the 7-d group and in 36.67% (11/30) patients in the 1-day group (P = 0.037). Side effects were induced by the treatment in 13.3% (4/30) patients of each group, but these were all self-limiting, short-lasting, and did not require any specific treatment. CONCLUSION: The one-day quadruple therapy is less effective than the one-week regimen in curing H pylori infection in Chinese patients. (c) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:3105 / 3107
页数:3
相关论文
共 15 条
[1]  
BELL GD, 1992, ALIMENT PHARM THERAP, V6, P427
[2]   One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection [J].
deBoer, WA ;
VanEtten, RJXM ;
Schade, RWB ;
Ouwehand, ME ;
Schneeberger, PM ;
VanUnnik, AJM ;
Tytgat, GNJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (01) :109-112
[3]  
Dobrucali A, 1997, DIGEST DIS SCI, V42, P2169, DOI 10.1023/A:1018851425080
[4]   Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates -: art. no. 20 [J].
Godoy, APO ;
Ribeiro, ML ;
Benvengo, YHB ;
Vitiello, L ;
Miranda, MDB ;
Mendonça, S ;
Pedrazzoli, J .
BMC GASTROENTEROLOGY, 2003, 3 (1)
[5]   FACTORS INFLUENCING THE ERADICATION OF HELICOBACTER-PYLORI WITH TRIPLE THERAPY [J].
GRAHAM, DY ;
LEW, GM ;
MALATY, HM ;
EVANS, DG ;
EVANS, DJ ;
KLEIN, PD ;
ALPERT, LC ;
GENTA, RM .
GASTROENTEROLOGY, 1992, 102 (02) :493-496
[6]   EFFECT OF RANITIDINE AND AMOXICILLIN PLUS METRONIDAZOLE ON THE ERADICATION OF HELICOBACTER-PYLORI AND THE RECURRENCE OF DUODENAL-ULCER [J].
HENTSCHEL, E ;
BRANDSTATTER, G ;
DRAGOSICS, B ;
HIRSCHL, AM ;
NEMEC, H ;
SCHUTZE, K ;
TAUFER, M ;
WURZER, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (05) :308-312
[7]   OMEPRAZOLE PLUS AMOXICILLIN FOR CURE OF HELICOBACTER-PYLORI INFECTION [J].
LABENZ, J ;
LEVERKUS, F ;
BORSCH, G .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 (12) :1070-1075
[8]   One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection [J].
Lara, LF ;
Cisneros, G ;
Gurney, M ;
Van Ness, M ;
Jarjoura, D ;
Moauro, B ;
Polen, A ;
Rutecki, G ;
Whittier, F .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (17) :2079-2084
[9]  
Lind T, 1996, Helicobacter, V1, P138, DOI 10.1111/j.1523-5378.1996.tb00027.x
[10]   IMPACT OF METRONIDAZOLE RESISTANCE ON THE ERADICATION OF HELICOBACTER-PYLORI [J].
NOACH, LA ;
LANGENBERG, WL ;
BERTOLA, MA ;
DANKERT, J ;
TYTGAT, GNJ .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1994, 26 (03) :321-327